Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $10.12 and last traded at $10.21, with a volume of 1907894 shares. The stock ...

Pediatric patients with sickle cell anemia and a history of abnormal cerebral artery velocities had reduced hospitalizations ...

Within a few days, I was shunted out of the hospital with some meds, and pamphlets and told by a cardiologist who looked and ...

Initiate pivotal studies for NX-5948: Nurix is evaluating NX-5948 in an ongoing Phase 1b clinical trial in adults with relapsed or refractory B-cell malignancies and expects to initiate a suite of ...

Initiate a suite of clinical trials in 2025 intended to support global registration of NX-5948 for the treatment of chronic lymphocytic ...

The diagnosis of hemolytic anemia was established mainly by the clinical observation of either a fall in circulating hemoglobin levels or a loss of transfused blood in excess of 1 per cent per day.

Physicians or patients who wish to participate in the 60 Degrees Pharmaceuticals Tafenoquine for Babesiosis Expanded Access clinical study are encouraged to visit the Company’s website for information ...

JNJ's filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of ...

KARACHI: Elephant Sonia housed at the Safari Park suffered from multiple chronic illnesses, affecting almost all vital organs ...

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

Agios Pharma submitted a sNDA to the FDA after two Phase III trials studying PYRUKYND (mitapivat) in thalassemia met their ...